Upon tumor progression, CAV1 levels strongly increase in malignant epithelial cells, which was correlated with worse clinical outcomes in a couple of cancer entities, including prostate, pancreatic, and lung cancer (31–36). The gene discussed is CAV1; the disease is cancer.